Creatinine measurements can be used to standardize urinary pesticide concentrations and to estimate ''completeness'' of urine collections. Published statistical models exist to predict 24-h creatinine, but many were developed assuming independence among observations. Using correlated repeated measurement data collected from an occupational cohort, the objectives were to create a predictive model for 24-h urinary creatinine and to compare the predictive capability of this model to earlier published models. Using a mixed-model methodology, the appropriate covariance structure was identified and utilized to model the measurements. A backwards elimination model building technique applied to the model building data set (110 adult male subjects and 457 creatinine values) yielded a final model that included variables for body mass index (BMI), height, diabetes, allergies, medical conditions that affect kidney function, use of creatine supplements, and anti-inflammatory medications. Using an external model validation data set (21 adult male subjects' creatinine values, n ¼ 91 observations from a total of 275) the predictive performance of the model was evaluated using the mean square prediction error (MSPR) and the Pearson's correlation coefficient (r); its performance was better (MSPR ¼ 279184, r ¼ 0.43) than any of the earlier models investigated (MSPR: range 658860-393139; r, range 0.18-0.38). In conclusion, the use of a covariance structure that allowed repeated measurements for any one individual to be correlated, improved the predictive performance. For purposes of incomplete urine sample identification in observational studies, it is necessary to collect information in addition to age, gender, and BMI, which are typically used in these settings.
Introduction
Creatinine (from muscle creatine) is a metabolic waste product removed from the blood by the kidneys and excreted in the urine (Katzung, 1989) . The concentration of creatinine in urine may vary based on a number of factors, including hydration, kidney function, age, gender, muscle mass, height, weight, emotional stress, exercise, and protein consumption (Turner and Cohn, 1975; Heymsfield et al., 1983; Kesteloot and Joossens, 1993; Proctor et al., 1999) .
The 24-h mass of creatinine in urine (mg/24 h) is used in the assessment of medical conditions, especially those relating to chronic kidney disease (Letteri et al., 1975; Johnson et al., 2004) , in investigating the relationship between creatinine and dietary protein intake (Kesteloot and Joossens, 1993; Poortmans et al., 1997) , in body composition studies (Welle et al., 1996) , and in estimating age-related muscle loss (Proctor et al., 1999) . Although recognizing that there will be some variation in urinary creatinine excretion within individuals over time, 24-h creatinine is often used in pesticide exposure research to aid in the determination of whether a urine sample is ''complete'' (Harris et al., 2000) . ''Complete'' in this context implies that all individual urine voids for a specified time period (usually 24 h) were captured. Complete urine collections are necessary for accurate estimation of absorbed dosage of a pesticide.
In studies conducted by Turner and Cohn (1975) ; Moriyama et al. (1988) ; Kawasaki et al. (1991) ; Jones et al. (1997) ; Harris et al. (2000) ; Kamata and Tochikubo (2002) ; Tanaka et al. (2002) ; Penie et al. (2003) , models were produced to predict 24-h urinary creatinine levels (mg). Some of the earlier models were built using a single measurement of creatinine for each subject (e.g., Tanaka et al., 2002) . A few of the other models (Turner and Cohn, 1975; Moriyama et al., 1988; Kawasaki et al., 1991; Harris et al. 2000) had repeated creatinine measurements for the same subject over time. Moriyama et al. (1988) and Harris et al. (2000) first aggregated the observations for one subject into a summary measure (e.g., mean) and then used this summary measure for the response variable. In Table 1 , the previously developed models are presented, sample sizes, and summary measures are provided, and studies with repeated measurements for any one subject are indicated. All of the prediction equations derived from these studies were built using ordinary least squares regression analysis. However, many of these studies had repeated creatinine measurements for each of their subjects. Observations stemming from repeated measurements on the same subject will most likely be correlated (Khattree and Naik, 1999) . Hence ordinary least squares regression, which assumes each observation is uncorrelated with the other observations, is not an appropriate technique to be used for this analysis.
Using correlated repeated measurement data from an occupational cohort study, the objectives of this work were to create a predictive model for 24-h urinary creatinine and to compare the predictive capability of the current model to earlier published models. For future statistical analysis, the model will be used to identify incomplete or suspect urine samples within the cohort of professional turf applicators.
Methods

Data Collection
The National Institute of Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention (CDC) funded a 4-year grant conducted for a national study entitled ''Pesticide Dose Monitoring in Turf Applicators.'' The overall goal of the study was to determine the absorbed dose, and factors that affect the absorbed dose, of various pesticides (including herbicides and insecticides) by the evaluation of the amount of parent compound or metabolites excreted in the urine of professional applicators who were exposed to these pesticides over time (Harris, 2006; Harris and Wells, 2007) . In this study, investigators collected questionnaire information on how these workers may have inhaled, ingested, or absorbed (through contact with the skin) these pesticides.
Study participants were asked to provide urine samples for multiple days during their workweeks. Each sample collected was the accumulated individual urine voids of a participant over a specific time period (either a 24-h or 12-h block of time). All urine samples were analyzed for six pesticide parent compounds and/or their metabolites. These samples also were tested for their creatinine concentration. Study participants were asked to provide additional information on their work schedules, their pesticide handling practices, existing health issues, diet information, and demographics.
Lawn care and tree and shrub workers employed by TruGreen ChemLawn were the volunteers for both the pilot and follow-on phases of this national study. The initial pilot phase was conducted in Richmond, Virginia in 2003 and consisted of three rounds of collections (one round in the summer, two rounds in the fall). The follow-on phase was conducted in five locations around the United States (Puyullap, Washington; Plainfield, Illinois; Plano, Texas; Salt Lake City, Utah; Sterling, Virginia). The follow-on phase had three rounds of collections: the first round was in the Spring of 2004, the second round was in the Summer of 2004 and the final round was completed in the Fall of 2004. Upon completion, there were 21 male subjects who participated in the pilot phase and 110 male subjects who participated in the follow-on phase.
For the pilot phase of the study, each subject was asked to collect his or her individual urine voids (into one container) for a 12-h period twice a day for five consecutive days (resulting in 10 containers per subject). In the fall months of 2003, the same subjects were then asked to collect their individual urine voids for 24-h collection periods each day for 14 consecutive days. For the follow-on phase of the study in 2004, during the spring round of collections, each subject was asked to collect their individual urine voids into one container for a 24-h period and then repeat the 24-h collection process All collected urine samples were shipped overnight to Virginia Commonwealth University for freezing and longterm storage. Creatinine concentrations were measured by Scientific Testing Laboratories in Richmond, Virginia using an automated method based on the Jaffe reaction. On the study questionnaire, each participant reported their age, body weight, height, gender, tobacco smoking habits, medical conditions that affect kidney function, adherence to a protein intensive diet, alcohol consumption, use of specific prescription medications, and use of creatine supplements.
Statistical Analysis: The Mixed Model
To create a predictive model for total 24-h urinary creatinine, two methods for accommodating correlated data were considered F generalized estimating equations (GEE) and random effects models (Vittinghoff et al., 2005) . Vittinghoff et al. (2005) suggest using generalized estimating equations when there are a large number of subjects and relatively few time points. They also indicate that GEE is limited in that ''it is restricted to a single level of clustering, it is not designed for inferences about the correlation structure, and it does not give predicted values for each cluster.'' GEE are better suited to inferential statistics than prediction. Complicating this analysis is that the data collected are unbalanced F the varying number of participants enrolled and completing the study in each season would yield an unequal number of observations for a specific time period. The urine collections for the follow-on phase were not equally spaced chronologically across all locations, also causing the data to be unbalanced (Vonesh and Chinchilli, 1997) .
Considering the unbalanced nature of the data and the goal to develop a predictive model, a mixed-model methodology (details are provided in Appendix A) was used to fit a model to predict a 24-h creatinine and to determine the withinsubject variation. Age at the time of collection, height, body weight, body mass index (BMI ¼ weight (kg)/height(m) 2 ), tobacco smoking habits, medical conditions that affect kidney function, protein intensive diets, alcohol consumption, prescription medications, and use of creatine diet supplements were considered as possible explanatory factors for this model. These factors were self reported by the subject at the start of each round, and are time varying factors (Khattree and Naik, 1999) . Complete race information was not available for this cohort, and thus could not be included as a possible predictive variable.
Covariance Structure Selection
A key element in this analysis was to identify the covariance structure of the within-subject variation (matrix R i ). Inadequate modeling of the covariance structure would result in biased estimates of variances of fixed effects estimates (Littell et al., 2006) . The potential correlation of the repeated measurements of the 24-h creatinine level for each subject was investigated by considering several covariance matrix structures. These included the unstructured, compound symmetric, first-order autoregressive, Toeplitz, ante-dependence, and spatial matrix structures (Jennrich and Schluchter, 1986; Littell et al., 2006) .
To determine which covariance structure best fits the data, an approach similar to what is outlined by Wolfinger (1993) was utilized. Using each of the potential covariance matrix structures, models that included all possible fixed factors were generated using release 9.1.3 of the SAS statistical software package (SAS Institute, Inc., 2003) . The results from these six covariance approaches were compared using lag time plots, likelihood ratio tests, and information criteria. A lag time plot shows covariance as a function of lag time between pairs of observations. This plot shows if, over time, the covariances are constant or if they are decreasing (or increasing). Lag is calculated as equal to one for measurements that are adjacent to each other (i.e., for the i th and the (i þ 1) th measurement); a lag of two is assigned for measurements two time units apart, etc.
The second step in the comparisons used likelihood ratio tests of the model under one covariance structure versus the same model under the unstructured covariance matrix. The appropriate likelihood ratio test statistic for the null hypothesis ''H o : R i has a specific covariance structure'' is:
where maximum likelihood is derived from the maximum likelihood method of Khattree and Naik (1999) , as opposed to the restricted maximum likelihood method (REML). When n is large, under the null hypothesis, this test statistic approximately follows a w 2 distribution with d.f. equal to the number of unknown parameters in the unstructured covariance matrix minus the number of unknown parameters in the covariance matrix specified in the null hypothesis.
Three information criteria were used to identify which covariance matrix is best (Littell et al., 2006) ; they included the Akaike Information Criterion (AIC), the finite-population corrected criteria developed by Burnham and Anderson (1998) , also known as the AICC (Burnham and Anderson, 1998) , and the Schwarz's Bayesian Information Criterion (BIC). The model (and hence the covariance structure used for it) that minimizes AIC or BIC is preferred (Littell et al., 2006) .
Determination of Model Predictor Factors and Evaluation of Assumptions
The follow-on phase data were used as the model building set and the pilot phase data as a model validation data set. For each of the 110 male subjects in the follow-on phase, there were up to six possible creatinine measurements. Of these 660 possible measurements, 457 observations had valid creatinine values and heights and weights, and these were used in the model building phase. Descriptive statistics for the male participants in the model building set are shown in Table 2 .
To build the 24-h creatinine model, the MIXED procedure of the statistical software package SAS (release 9.1.3) was used (SAS Institute Inc., 2003) . Under the assumption of joint multivariate normality for the random effects (n) and the error term (e) in the mixed model, this procedure uses the REML methodology (as its default) to estimate the covariance parameters (i.e., the G and the R matrices) (Khattree and Naik, 1999) . As shown in Appendix B, the covariance parameter estimates (Ĝ and R) can then be used to obtain the fixed effect estimates via generalized least square estimates (Littell et al., 2006) .
A backwards elimination technique outlined by Kutner et al. (2005) was used to build the model, using a 0.05 significance level for each predictor to remain in the model when it was tested individually. As noted earlier, the potential explanatory factors were placed in the matrix of constants that describe the structure of the study with respect to fixed effects (i.e., the X i matrix in the mixed model). The test statistic used for the P-value comparison in the backwards elimination was the resultant F-test statistic from the Type 3 test for the fixed effects. Based on the earlier covariance structure analysis, the compound symmetric structure was used for this model. The Kenward-Roger correction for the denominator d.f. (Kenward and Roger, 1997) for the Type 3 F-test statistic was used to handle the possible bias introduced by using this non-independent covariance structure (Littell et al., 2006) . A model (with all possible predictor variables in it) was the starting point. Predictor variables such as height, weight, BMI, and age at the time of collection were considered to be covariates in the model. Predictor variables, to indicate that the subject was a smoker, took a prescription medication, had a medical condition, etc., were represented as classification variables in the model. Based on the study questionnaire completed by the subjects, there were up to three possible values for the classification variables: a negative response, an affirmative response, and a response of ''not answered''. Possible interaction terms also were included in this initial model, but few could be assessed due to the sparseness of the data.
Model Validation
For each of the 21 subjects in the pilot phase of the study, up to 19 days of 24-h creatinine measurements were possible and validation of the final model was completed using a subset of these pilot data. The pilot data consisted of three rounds: the first round was 5 consecutive days with two 12-h collections for each of the days; the second and third rounds (several months later) consisted of 24-h collection periods for two consecutive 1-week periods (resulting in a total of 7 days for round two and the next 7 days for round three). To create a model validation data set from the pilot phase data that closely resembled the lapses in time between the three rounds of the follow-on phase, days 1 and 2 from round one were included in the validation data set. The first 2 days from round two also were included in the validation data set. From the 7 days in the third round, one of the first 6 days was selected at random (day i); both day i and day (i þ 1) were then included in the validation data set.
Comparison With Other Models
The initial step for the model comparisons was a review of the participant age, height, and weight information for the previously cited studies. As shown in Tables 2 and 3, the ages of the male study participants for the NIOSH-CDC study are in the same range as the ages of participants from these earlier studies (see Table 1 ). Applying Chebyshev's Theorem, where at least 75% of the items in any data set are within ±2 SD of the mean (Anderson et al., 1993) , comparisons were made for the heights and weights of the subjects in the different studies. Next, the models by Turner and Cohn (1975) Penie et al. (2003) were used to calculate predicted values for the model building data set from the NIOSH-CDC study. The models of Kamata and Tochikubo (2002) and of Jones et al. (1997) were not included in this comparison because of the unavailability of subjects' lean body mass measurements (for the Kamata model) and because of all of the original study's subjects being continuous ambulatory peritoneal dialysis patients (for the Jones model).
To compare the predictive capability of the regression models, the mean squared prediction error (MSPR) was calculated for each model (Kutner et al., 2005) . A second measure used to evaluate the predictive capability of the models was the Pearson's correlation coefficient (r) between the predicted creatinine values and the observed creatinine values.
Results
NIOSH Creatinine Data: Covariance Structure Selection
The covariance estimates versus lag in time when the unstructured covariance matrix is used for the model building data are shown in the plot in Figure 1 .
As shown in Figure 1 , as lag increases, the covariance estimates tend to flatten out. This would suggest that a compound symmetric covariance approach, where the correlation between the i th and j th time is constant for a subject (Littell et al., 2006) , may be appropriate.
Each likelihood ratio test statistic for a null hypothesis of independent covariance matrix structure versus any of the other covariance structures considered, resulted in the null hypothesis being rejected, and it was concluded that the independent covariance matrix structure was not appropriate. In Table C1 (Appendix C) the results of the likelihood ratio tests comparing the other covariance structures to the unstructured case (rather than the independent case) are presented. The likelihood ratio tests suggest that of the covariance structures considered, the compound symmetric approach and the Toeplitz approach are the most favorable candidates (not significantly different from the unstructured case). However, as noted by Littell et al. (2006) , the Toeplitz covariance structure is appropriate only when the repeated measurements are equally spaced chronologically. Although it is true that the measures within one round were equally spaced (i.e., equal to a 1-day lapse in time across all locations), the lapse in time between rounds was not the same for all locations. Hence, selecting the Toeplitz covariance structure over the compound symmetric structure, based on this likelihood ratio test, is deemed unwise. Table C2 shows the information criteria for each of the covariance structures tested. The compound symmetric approach represents the minimum value for each of these criteria and hence would be the covariance matrix of choice using these criteria. Lastly, Figure 2 shows a graphical comparison of the covariance estimates versus lag in time for the unstructured, compound symmetric, first-order autoregressive (1), Toeplitz, and ante-dependence covariance approaches. This graph suggests that the compound symmetric approach for the within-subject errors is appropriate because it tracks closest to the covariance estimates from the unstructured approach.
Based on the graphical, likelihood ratio, and information criteria comparisons, and the fact that the repeated measurements were not equally spaced chronologically, the compound symmetric covariance structure was considered the most appropriate covariance matrix structure to use in the ensuing model building effort.
NIOSH Creatinine Data: Determination of Model Predictor Factors
The final fitted model included the predictors of body mass index, height and the classification variables for diabetes, for allergies, for a medical condition that affects kidney function (e.g., high blood pressure, glomerulonephritis), for the usage of a creatine supplement, and for use of an anti-inflammatory medication. None of the interaction terms remained in the final model. The final model may be expressed as: creatinine ¼ À 2457:55 þ 37:67ÂBMI þ 13:36Âheightþ diabetes þ allergies þ medconditionþ creatine supp þ anti inflammatory where: BMI ¼ body mass index (kilograms per squared meter); height ¼ subject height (in centimeters); diabetes ¼ À496.55 if subject had diabetes; allergies ¼ À1135.39 if subject did not have allergies, ¼ À1430.22 if subject had allergies; medcondition ¼ 1893.01 if subject did not have a medical condition that affected kidney function, ¼ 1877.42 if subject did have a medical condition; creatine_supp ¼ 8.30 if subject did not use creatine supplements, ¼ À517.70 if subject did use creatine supplements; anti_infla-mmatory ¼ À599.40 if subject did use an anti-inflammatory.
Owing to the compound symmetry, the intra-class correlation coefficient (ICC, r), which is the correlation between any two measures on the same subject, was calculated to be 0.50 (Littell et al., 2006) .
To validate the assumptions for the error term, a residual analysis was performed on the residuals emanating from the final model. For the mixed model, there are marginal residuals (r mi ¼ y i À x 0 ib ) and conditional residuals (r ci ¼ y i À x 0 ib À z 0 in ) (Schabenberger, 2004) . Schabenberger (2004) points out that in a mixed model without random effects, (i.e., the model used here) the marginal and conditional residuals are the same. Further, the raw marginal residuals, (r mi ), are not well suited to examine mixed model assumptions because their variances could differ. Studentized residuals address this unequal variance concern by dividing a raw residual by an estimate of its SD. A review of the Studentized plots suggested there were no violations of the assumptions surrounding the error term e BNormal (0,R). 
NIOSH Creatinine Data: Model Validation
For the 21 subjects in the pilot phase of the study, a maximum of 126 observations in the validation data set were possible. Of the possible observations, 91 had valid creatinine values, heights, and weights and thus were usable in the model validation phase. Table 3 shows the descriptive statistics for the model validation observations. Predicted 24-h creatinine, using the final model's parameter estimates, were calculated for each observation in the model validation data set and a comparison of the association between the predicted and actual 24-h creatinine values, using the Pearson's correlation coefficient (r), was completed for both the model building data set and the model validation data set. For the model building data, r was equal to 0.43; for the model validation data, r was slightly lower with a value of 0.32.
A plot of the predicted 24-h creatinine values versus the observed creatinine values, for both data sets, is shown in Figure 3 . This plot, along with the correlation coefficients for predicted versus actual creatinine values, suggests that the model's predictive behavior for the validation data is similar to its predictive behavior from the model building data.
Comparison of Prediction Results to Other Models
Applying Chebyshev's Theorem (Anderson et al., 1993) we found that the range of heights and weights of the NIOSH-CDC study participants were similar to those from the Turner and Cohn (1975) ; Harris et al. (2000) studies. The range of heights and weights of the participants in the Moriyama et al. (1988) ; Kamata and Tochikubo (2002) ; Tanaka et al. (2002) ; Penie et al. (2003) studies are slightly lower than those for the NIOSH-CDC study participants.
To evaluate the predictive abilities of the model the MSPR was calculated. Intuitively, a smaller MSPR is better, as the MSPR provides a model-specific summary measure of the model's ''error in prediction'' for all of the applicable observations in the NIOSH-CDC study model building data set. An ordered list (in descending order) of the MSPR results is shown in Table 4 . It is clear that the current model developed has the smallest MSPR for this NIOSH-CDC study data.
The Kawasaki, Moriyama, Tanaka, Harris, Turner, and Penie models listed in this table did not have data for all of the potential predictors (e.g., to indicate usage of creatine supplements, having allergies, etc.) available for their study subjects that were available for the model in this current work. Thus, the model listed as ''Revised Model'' was developed using the model building data set from the NIOSH-CDC study data, using the REML method for a mixed model and a compound symmetric covariance structure. This ''Revised Model'' was built to illustrate the predictive performance of a model incorporating the proper covariance structure using only the same predictors that were available to the comparison models at the time of their studies (i.e., subject height, weight, and age at collection). This model also yielded a much smaller MSPR than the comparison models. Table 4 displays the correlation coefficients for the models, and indicates that the current project model has the largest correlation value.
Discussion
The measurement of creatinine is used in the assessment and monitoring of many medical conditions as well as in the area of human exposure and biological monitoring research. As noted earlier a number of studies have been conducted and there are multiple statistical-based models that can be used to predict 24-h urinary creatinine levels; however, in a number of these studies, multiple measurements of creatinine within individuals were treated as independent observations. Our approach allowed for the identification and the specification of a covariance structure that would account for the observations within one individual being correlated. The resultant model contained the covariates of height and body mass index, and the classification variables to indicate if the study participant had allergies, diabetes, or some other medical condition that affected kidney function. It also included the classification variables that indicated if the participant was taking an antiinflammatory prescription medication or was using a creatine dietary supplement.
The predictive performance of our model, as evaluated by the MSPR and the correlation coefficient, for the NIOSH-CDC pesticide data, was better than the predictive performance of any of the other published models noted in this article. As noted in the model comparisons, the range of ages was comparable for both the NIOSH-CDC study participants and the other studies' subjects. The body size characteristics for the NIOSH-CDC participants were slightly larger than those in the Moriyama et al. (1988) ; Tanaka et al. (2002) ; Penie et al. (2003) studies. This may explain some of the difference in predictive capabilities between these models and the final model built for this project. However, the NIOSH-CDC study participants were more similar in height and weight to those of the Turner and Cohn (1975) ; Harris et al. (2000) studies, therefore, dissimilarity in body size is not a likely reason for the difference in predictive capability. The second possible reason for the improved predictive capability of the final model, versus the others, is that all of the other models assumed that the measurements within one individual were uncorrelated. Littell et al. (2006) noted that ignoring important correlation by using a ''too simple'' covariance model can risk underestimating SE. The work of Guerin and Stroup (2000) , in documenting the effects of various covariance modeling decisions using the SAS mixed model procedure for repeated-measures data, also showed that ''inference is severely compromised by a poor choice of covariance model.'' The improved predictive capability of the current model, over the others, may very well be attributed to its identification and usage of a covariance structure that allowed the repeated measurements for any one individual to be correlated. Development of a urinary creatinine prediction model Kroos et al.
Owing to the random vectors n and e in this mixed model, there are two possible distributions to consider F the conditional distribution of (y |n) and the marginal distribution of y as shown here (Littell et al., 2006) :
By using the mixed model approach, it is possible to obtain insight into the within-subject variation, over time, for the total 24-h urinary creatinine level. The within-subject variation for subject i would be contained in the R i covariance matrix referenced in the mixed model description shown above. The potential explanatory factors of age, height, weight, BMI, etc. are placed in the matrix of constants that describe the structure of the study with respect to fixed effects (i.e., the X i matrix). No explanatory factors are placed in the model in the matrix of constants that describe the study's structure with regard to random effects (i.e., the matrix Z i ¼ 0). Hence, for this study's model, n is a zero vector, G is a zero matrix, no random effects will be estimated, and the variation will be modeled through the R matrix.
